Therapeutic cloning has been suggested as a new strategy to treat a number of diseases. Based on the recent breakthrough made by Korean scientists, here the progresses in the field of therapeutic cloning were reviewed and two important issues in this field: the reprogramming after nuclear transfer and the establishment, self-renewal and differentiation of human embryonic stem cells were discussed. The great significance and existing challenges of therapeutic cloning strategy were also prospected.